glp-1 colitis The alleviating effect and mechanism of on ulcerative Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
EGLP-35K

In females, the GLP-1 receptor agonists should not be taken during pregnancy or while breastfeeding, Lee said

The FDA declared the semaglutide shortage resolved in February 2025

[DOI] [PMC free article] [PubMed] [Google Scholar] 49.Noyan-Ashraf MH, et al
